Fecal Microbiota Transplant
Fecal Microbiota Transplant is a biological therapy with 28 clinical trials. Currently 1 active trials ongoing. Historical success rate of 80.0%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
15
Early Stage
4
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
70.6%
12 of 17 finished
29.4%
5 ended early
1
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Fecal Microbiome Transplant
Fecal Microbiota Transplant
Transfer of Feces in Ulcerative Colitis 2
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Clinical Trials (28)
Fecal Microbiome Transplant
Fecal Microbiota Transplant
Transfer of Feces in Ulcerative Colitis 2
Familial Fecal Microbiota Transplant for the Treatment of Subjects With Autism Spectrum Disorders
Pilot Feasibility Study of Fecal Microbiota Transplant for the Treatment of Small Intestinal Bacterial Overgrowth
Fecal MicrobiotaTransplant for the Treatment of Parkinson's Disease
Fecal Microbiota Transplant for Anorexia Nervosa
FMT In High-Risk Acute GVHD After ALLO HCT
Preterm Infant Intestinal Microbiota Development and Maternal Fecal Transplant
Fecal Microbiota Transplantation for Decolonization of Carbapenem-resistant Enterobacteriaceae
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Fecal Microbiota Transplantation (FMT) for MDRO UTI
Efficacy and Safety of Fecal Microbiota Transplant for Secondary Prophylaxis of Hepatic Encephalopathy
A Prospective Trial of Frozen-and-Thawed Fecal Microbiota Transplantation for Recurrent Clostridium Difficile Infection
Fecal Microbiota Transplantation (FMT) in the Management of Hepatic Encephalopathy (HE): a Pilot Study
FEcal Transplant, a Hope to Eradicate Colonization of Patient Harboring eXtreme Drug Resistant Bacteria?
Oral Fecal Microbiota Transplant Feasibility Study in Alzheimer's Disease
To Assess the Role of Fecal Microbiota Transplant in Acute Liver Failure
FMT Delivered by Capsule Versus Colonoscopy for Recurrent C. Diff
A Single Dose FMT Infusion as an Adjunct to Keytruda for Metastatic Mesothelioma
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 28